We are live on ! Find out more
FNFDCM

Folger Nolan Fleming Douglas Capital Management Portfolio holdings

AUM $1.22B
1-Year Est. Return 34.81%
This Fund
S&P 500
This Quarter Est. Return
+9.76%
1 Year Est. Return
+34.81%
3 Year Est. Return
+67.26%
5 Year Est. Return
+81.95%
10 Year Est. Return
+255.15%
AUM
$573M
AUM Growth
+$54.3M
Cap. Flow
+$4.72M
Cap. Flow %
0.82%
Top 10 Hldgs %
59.15%
Holding
175
New
9
Increased
63
Reduced
43
Closed
5

Sector Composition

Rank Sector Weight
1 Materials 37.78%
2 Consumer Staples 9.18%
3 Industrials 8.62%
4 Energy 8.26%
5 Healthcare 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VWO icon
51
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$2.09M 0.37%
50,855
-530
-1% -$21.9K
DIS icon
52
Walt Disney
DIS
$181B
$2.04M 0.36%
26,717
+590
+2% +$40.9K
WFM
53
DELISTED
Whole Foods Market Inc
WFM
$1.97M 0.34%
33,980
-95
-0.3% -$5.63K
EFA icon
54
iShares MSCI EAFE ETF
EFA
$80.2B
$1.92M 0.33%
28,579
+400
+1% +$26.1K
V icon
55
Visa
V
$677B
$1.88M 0.33%
33,820
+4,180
+14% +$211K
SE
56
DELISTED
Spectra Energy Corp Wi
SE
$1.86M 0.33%
52,370
+1,288
+3% +$44.3K
MAR icon
57
Marriott International
MAR
$92.3B
$1.81M 0.32%
36,717
-1,571
-4% -$71.5K
NEE icon
58
NextEra Energy
NEE
$177B
$1.8M 0.31%
84,100
+1,040
+1% +$21.9K
MTB icon
59
M&T Bank
MTB
$36.2B
$1.75M 0.31%
15,050
VO icon
60
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$1.68M 0.29%
60,900
+3,580
+6% +$95.3K
KO icon
61
Coca-Cola
KO
$375B
$1.66M 0.29%
40,141
TGT icon
62
Target
TGT
$68B
$1.66M 0.29%
26,193
+395
+2% +$25.3K
PFE icon
63
Pfizer
PFE
$153B
$1.55M 0.27%
53,453
-471
-0.9% -$13.7K
IBB icon
64
iShares Biotechnology ETF
IBB
$9.71B
$1.52M 0.27%
20,061
+3,240
+19% +$230K
GIS icon
65
General Mills
GIS
$19.7B
$1.51M 0.26%
30,357
-175
-0.6% -$8.71K
BA icon
66
Boeing
BA
$185B
$1.51M 0.26%
11,075
-50
-0.4% -$6.5K
EMR icon
67
Emerson Electric
EMR
$88.3B
$1.45M 0.25%
20,681
-190
-0.9% -$12.7K
VB icon
68
Vanguard Morningstar Small-Cap ETF
VB
$82.7B
$1.42M 0.25%
12,930
+700
+6% +$74.5K
HSY icon
69
Hershey
HSY
$36.6B
$1.42M 0.25%
14,560
-200
-1% -$19.2K
BEN icon
70
Franklin Resources
BEN
$17.2B
$1.35M 0.24%
23,319
WGL
71
DELISTED
Wgl Holdings
WGL
$1.31M 0.23%
32,830
-1,094
-3% -$45.5K
DUK icon
72
Duke Energy
DUK
$97.3B
$1.31M 0.23%
18,994
AMGN icon
73
Amgen
AMGN
$222B
$1.22M 0.21%
10,725
-35
-0.3% -$3.98K
BAC icon
74
Bank of America
BAC
$442B
$1.19M 0.21%
76,425
-5,073
-6% -$75.3K
SIAL
75
DELISTED
SIGMA - ALDRICH CORP
SIAL
$1.19M 0.21%
12,600

Similar funds

Folger Nolan Fleming Douglas Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Folger Nolan Fleming Douglas Capital Management held 175 positions worth $573M, up 10% from $518M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Folger Nolan Fleming Douglas Capital Management's Q4 2013 filing shows 9 new, 63 increased, 43 reduced and 5 closed positions. Its largest new stake was Vodafone: 5,494 shares worth $220K. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $201K.

By sector, the portfolio is most concentrated in Materials at 38% of assets, up from 37% a quarter earlier, followed by Consumer Staples and Industrials.

  • Folger Nolan Fleming Douglas Capital Management's largest Q4 2013 buy was Vodafone: 5,494 shares worth $220K.
  • Folger Nolan Fleming Douglas Capital Management added most to Du Pont De Nemours E I in Q4 2013, an estimated $964K increase.
  • Folger Nolan Fleming Douglas Capital Management's biggest Q4 2013 reduction was Elme Communities, cutting an estimated $140K.
  • Folger Nolan Fleming Douglas Capital Management fully exited iShares MSCI Emerging Markets ETF in Q4 2013, selling an estimated $201K.
  • Folger Nolan Fleming Douglas Capital Management's ten largest holdings make up 59% of its $573M portfolio in Q4 2013.
  • Folger Nolan Fleming Douglas Capital Management opened 9 new positions and closed 5 in Q4 2013.
  • Folger Nolan Fleming Douglas Capital Management's portfolio value rose 10% quarter-over-quarter to $573M.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q4 2013, filed 22 Jan 2014.